Viewing Study NCT00335868


Ignite Creation Date: 2025-12-24 @ 5:45 PM
Ignite Modification Date: 2026-02-11 @ 2:37 PM
Study NCT ID: NCT00335868
Status: UNKNOWN
Last Update Posted: 2013-12-18
First Post: 2006-06-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: PHA-739358 in Treating Patients With Chronic Myelogenous Leukemia That Relapsed After Imatinib Mesylate or c-ABL Therapy
Sponsor: Jonsson Comprehensive Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None accelerated phase chronic myelogenous leukemia View
None blastic phase chronic myelogenous leukemia View
None chronic phase chronic myelogenous leukemia View
None relapsing chronic myelogenous leukemia View